218 related articles for article (PubMed ID: 21623707)
1. Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.
Decleves X; Jacob A; Yousif S; Shawahna R; Potin S; Scherrmann JM
Curr Drug Metab; 2011 Oct; 12(8):732-41. PubMed ID: 21623707
[TBL] [Abstract][Full Text] [Related]
2. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.
Dauchy S; Dutheil F; Weaver RJ; Chassoux F; Daumas-Duport C; Couraud PO; Scherrmann JM; De Waziers I; Declèves X
J Neurochem; 2008 Dec; 107(6):1518-28. PubMed ID: 19094056
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.
Shawahna R; Uchida Y; Declèves X; Ohtsuki S; Yousif S; Dauchy S; Jacob A; Chassoux F; Daumas-Duport C; Couraud PO; Terasaki T; Scherrmann JM
Mol Pharm; 2011 Aug; 8(4):1332-41. PubMed ID: 21707071
[TBL] [Abstract][Full Text] [Related]
4. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
[TBL] [Abstract][Full Text] [Related]
5. Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.
Chaves C; Remiao F; Cisternino S; Decleves X
Curr Neuropharmacol; 2017 Nov; 15(8):1156-1173. PubMed ID: 28474563
[TBL] [Abstract][Full Text] [Related]
6. ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders.
Dutheil F; Jacob A; Dauchy S; Beaune P; Scherrmann JM; Declèves X; Loriot MA
Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1161-74. PubMed ID: 20843279
[TBL] [Abstract][Full Text] [Related]
7. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.
Warren MS; Zerangue N; Woodford K; Roberts LM; Tate EH; Feng B; Li C; Feuerstein TJ; Gibbs J; Smith B; de Morais SM; Dower WJ; Koller KJ
Pharmacol Res; 2009 Jun; 59(6):404-13. PubMed ID: 19429473
[TBL] [Abstract][Full Text] [Related]
8. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
[TBL] [Abstract][Full Text] [Related]
9. PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.
Vlaming ML; Läppchen T; Jansen HT; Kivits S; van Driel A; van de Steeg E; van der Hoorn JW; Sio CF; Steinbach OC; DeGroot J
Nucl Med Biol; 2015 Nov; 42(11):833-41. PubMed ID: 26264927
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders.
Gil-Martins E; Barbosa DJ; Silva V; Remião F; Silva R
Pharmacol Ther; 2020 Sep; 213():107554. PubMed ID: 32320731
[TBL] [Abstract][Full Text] [Related]
12. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells.
Dauchy S; Miller F; Couraud PO; Weaver RJ; Weksler B; Romero IA; Scherrmann JM; De Waziers I; Declèves X
Biochem Pharmacol; 2009 Mar; 77(5):897-909. PubMed ID: 19041851
[TBL] [Abstract][Full Text] [Related]
13. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
14. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
[TBL] [Abstract][Full Text] [Related]
15. [¹¹C]befloxatone brain kinetics is not influenced by Bcrp function at the blood-brain barrier: a PET study using Bcrp TGEM knockout rats.
Hosten B; Boisgard R; Jacob A; Goutal S; Saubaméa B; Dollé F; Scherrmann JM; Cisternino S; Tournier N
Eur J Pharm Sci; 2013 Nov; 50(3-4):520-5. PubMed ID: 23981334
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
Löscher W; Potschka H
NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
[TBL] [Abstract][Full Text] [Related]
17. Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analogues.
Lin F; Marchetti S; Pluim D; Iusuf D; Mazzanti R; Schellens JH; Beijnen JH; van Tellingen O
Clin Cancer Res; 2013 Apr; 19(8):2084-95. PubMed ID: 23461902
[TBL] [Abstract][Full Text] [Related]
18. ABC transporters and the blood-brain barrier.
Begley DJ
Curr Pharm Des; 2004; 10(12):1295-312. PubMed ID: 15134482
[TBL] [Abstract][Full Text] [Related]
19. [The drug-drug interaction mediated by efflux transporters and CYP450 enzymes].
Wang C; Liu KX
Yao Xue Xue Bao; 2014 May; 49(5):590-5. PubMed ID: 25151726
[TBL] [Abstract][Full Text] [Related]
20. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier.
Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T
Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
